Business Description
Sonic Healthcare Ltd
ISIN : AU000000SHL7
Share Class Description:
ASX:SHL: Ordinary SharesTotal Employee Number:
41,000Description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.7 | |||||
Debt-to-EBITDA | 3.38 | |||||
Interest Coverage | 7 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.97 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.2 | |||||
3-Year EBITDA Growth Rate | -15.8 | |||||
3-Year EPS without NRI Growth Rate | -29.3 | |||||
3-Year FCF Growth Rate | -23.2 | |||||
3-Year Book Growth Rate | 4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10.52 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.64 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.45 | |||||
9-Day RSI | 47.59 | |||||
14-Day RSI | 52.77 | |||||
3-1 Month Momentum % | -0.45 | |||||
6-1 Month Momentum % | -14.06 | |||||
12-1 Month Momentum % | -26.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.01 | |||||
Quick Ratio | 0.9 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 52.24 | |||||
Days Sales Outstanding | 49.35 | |||||
Days Payable | 202.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.98 | |||||
Dividend Payout Ratio | 0.97 | |||||
3-Year Dividend Growth Rate | 4 | |||||
Forward Dividend Yield % | 4.98 | |||||
5-Year Yield-on-Cost % | 6.37 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | 9.02 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 83.4 | |||||
Operating Margin % | 9.14 | |||||
Net Margin % | 5.19 | |||||
EBITDA Margin % | 16.94 | |||||
FCF Margin % | 7.17 | |||||
OCF Margin % | 13.07 | |||||
ROE % | 6.45 | |||||
ROA % | 3.34 | |||||
ROIC % | 4.68 | |||||
3-Year ROIIC % | 35.46 | |||||
ROC (Joel Greenblatt) % | 26.05 | |||||
ROCE % | 6.62 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.09 | |||||
Forward PE Ratio | 16.37 | |||||
PE Ratio without NRI | 19.09 | |||||
Shiller PE Ratio | 12.6 | |||||
Price-to-Owner-Earnings | 10.63 | |||||
PS Ratio | 0.99 | |||||
PB Ratio | 1.22 | |||||
Price-to-Free-Cash-Flow | 13.78 | |||||
Price-to-Operating-Cash-Flow | 7.59 | |||||
EV-to-EBIT | 17.79 | |||||
EV-to-Forward-EBIT | 16.32 | |||||
EV-to-EBITDA | 9.24 | |||||
EV-to-Forward-EBITDA | 9.07 | |||||
EV-to-Revenue | 1.56 | |||||
EV-to-Forward-Revenue | 1.41 | |||||
EV-to-FCF | 21.96 | |||||
Price-to-GF-Value | 0.64 | |||||
Price-to-Projected-FCF | 0.57 | |||||
Price-to-Median-PS-Value | 0.56 | |||||
Earnings Yield (Greenblatt) % | 5.62 | |||||
FCF Yield % | 6.95 | |||||
Forward Rate of Return (Yacktman) % | 8.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sonic Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 10,395.706 | ||
| EPS (TTM) (A$) | 1.106 | ||
| Beta | 1.0243 | ||
| 3-Year Sharpe Ratio | -0.93 | ||
| 3-Year Sortino Ratio | -1.07 | ||
| Volatility % | 24.71 | ||
| 14-Day RSI | 52.77 | ||
| 14-Day ATR (A$) | 0.475028 | ||
| 20-Day SMA (A$) | 21.194 | ||
| 12-1 Month Momentum % | -26.56 | ||
| 52-Week Range (A$) | 18.26 - 29.24 | ||
| Shares Outstanding (Mil) | 494.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sonic Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sonic Healthcare Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-11-19 10:00 | In 122 days | ||
| Annual report for 2026 | 2026-09-24 | In 65 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-20 10:00 | In 31 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-20 | In 30 days | ||
| AUD 0.450000 Cash Dividend | 2026-03-04 | 23.64 (-0.38%) | ||
| Second quarter earnings conference call for 2026 | 2026-02-19 10:00 | 21.24 (-0.28%) | ||
| Second quarter earnings results for 2026 | 2026-02-19 | 21.24 (-0.28%) | ||
| General meeting for 2025 | 2025-11-20 10:00 | 21.49 (+2.33%) | ||
| Annual report for 2025 | 2025-09-24 | 22.08 (-0.94%) | ||
| AUD 0.630000 Cash Dividend | 2025-09-03 | 23.75 (-1.04%) |
Show
Entries
Sonic Healthcare Ltd Frequently Asked Questions
What is Sonic Healthcare Ltd(ASX:SHL)'s stock price today?
The current price of ASX:SHL is A$21.12. The 52 week high of ASX:SHL is A$29.24 and 52 week low is A$18.26.
When is next earnings date of Sonic Healthcare Ltd(ASX:SHL)?
The next earnings date of Sonic Healthcare Ltd(ASX:SHL) is 2026-08-20.
Does Sonic Healthcare Ltd(ASX:SHL) pay dividends? If so, how much?
The Dividend Yield %  of Sonic Healthcare Ltd(ASX:SHL) is 4.98% (As of Today), Highest Dividend Payout Ratio of Sonic Healthcare Ltd(ASX:SHL) was 1. The lowest was 0.31. And the median was 0.7. The  Forward Dividend Yield % of Sonic Healthcare Ltd(ASX:SHL) is 4.98%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sonic Healthcare Ltd
No articles.